BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28254159)

  • 21. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Nell S; Borel Rinkes IHM; Verkooijen HM; Bonsing BA; van Eijck CH; van Goor H; de Kleine RHJ; Kazemier G; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; Vriens MR;
    Ann Surg; 2018 Feb; 267(2):352-356. PubMed ID: 27811505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standard pre- and postoperative determination of chromogranin a in resectable non-functioning pancreatic neuroendocrine tumors--diagnostic accuracy: NF-pNET and low tumor burden.
    Jilesen AP; Busch OR; van Gulik TM; Gouma DJ; Nieveen van Dijkum EJ
    Dig Surg; 2014; 31(6):407-14. PubMed ID: 25572908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.
    Tanaka M; Heckler M; Mihaljevic AL; Probst P; Klaiber U; Heger U; Schimmack S; Büchler MW; Hackert T
    Ann Surg Oncol; 2021 Mar; 28(3):1614-1624. PubMed ID: 32720049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life.
    Partelli S; Mazza M; Andreasi V; Muffatti F; Crippa S; Tamburrino D; Falconi M
    Surgery; 2019 Aug; 166(2):157-163. PubMed ID: 31109657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.
    Crippa S; Partelli S; Zamboni G; Scarpa A; Tamburrino D; Bassi C; Pederzoli P; Falconi M
    Surgery; 2014 Jan; 155(1):145-53. PubMed ID: 24646958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours.
    Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
    ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment options for PNET liver metastases: a systematic review.
    Nigri G; Petrucciani N; Debs T; Mangogna LM; Crovetto A; Moschetta G; Persechino R; Aurello P; Ramacciato G
    World J Surg Oncol; 2018 Jul; 16(1):142. PubMed ID: 30007406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.
    Lee LC; Grant CS; Salomao DR; Fletcher JG; Takahashi N; Fidler JL; Levy MJ; Huebner M
    Surgery; 2012 Dec; 152(6):965-74. PubMed ID: 23102679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
    Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
    Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?
    Hodul PJ; Strosberg JR; Kvols LK
    Cancer Control; 2008 Oct; 15(4):314-21. PubMed ID: 18813199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
    Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
    Cloyd JM; Poultsides GA
    World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural History of Small Pancreatic Lesions Suspected to Be Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Choi JH; Choi YH; Kang J; Paik WH; Lee SH; Ryu JK; Kim YT
    Pancreas; 2018; 47(10):1357-1363. PubMed ID: 30308537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.
    Kappelle WF; Valk GD; Leenders M; Moons LM; Bogte A; Siersema PD; Vleggaar FP
    Endoscopy; 2017 Jan; 49(1):27-34. PubMed ID: 27975336
    [No Abstract]   [Full Text] [Related]  

  • 36. Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).
    Jung JG; Lee KT; Woo YS; Lee JK; Lee KH; Jang KT; Rhee JC
    Medicine (Baltimore); 2015 Jul; 94(26):e983. PubMed ID: 26131843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Barenboim A; Lahat G; Nachmany I; Nakache R; Goykhman Y; Geva R; Osher E; Scapa E; Wolf I; Orbach L; Brazowski E; Isakov O; Klausner JM; Lubezky N
    J Gastrointest Surg; 2020 Jun; 24(6):1366-1374. PubMed ID: 31197692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.